Delivery Order SPE2DB25D3404-SPE2DB25FUQMS
Award Date 9/18/25
Potential Completion Date 10/9/25
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,019.28 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 22, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $48,077.16 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 9, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $24,038.58 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price delivery order with an ultimate completion date of June 24, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $22,618.72 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to provide Ocrevus 300 MG/10 ML vials. Performance will take place in Conshohocken, Pennsylvania over a period of approximately one month, from September 29th through October 23rd, 2023. The Defense Logistics Agency Troop Support Medical supports the Department of Defense by procuring pharmaceuticals...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ocrevus 300 mg/10 ml vials with a ceiling value of $85,193.27. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ocrevus 300 mg/10 mL vials valued at $48,077.16. This is a firm fixed-price delivery order with an ultimate completion date of October 9, 2025, and represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $120,192.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus (ocrelizumab) 300 mg/10 mL vials. This is a non-set-aside competitive award with an ultimate completion date of October 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the contract at its corporate office location. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,019.28 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. This firm fixed price contract, awarded on July 23, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $23,118.08. The order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a specialty pharmaceutical product, with a completion date of February 26, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide a range of pharmaceutical and medical supplies in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $72,115.74. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp will perform this work at its corporate office location in Conshohocken, Pennsylvania. Ocrevus is a specialty pharmaceutical product...